Stock listing

NASDAQ:BONS Bonus Biogroup Ltd. Stock

US listing (NASDAQ) of Bonus Biogroup Ltd. · home listing TASE:BONS

Follow Bonus Biogroup Ltd. into a list and get an email when it puts out news.

Home listing price · TASE:BONS

16.50 ILA (agorot) -0.30 (-1.8%)

Close on Oct 15, 2026 · This listing has no price on 6ix; the price shown is the home listing's, TASE:BONS

Ticker: NASDAQ:BONS
Asset type: Stock
Sector: Health care
Industry: Biotechnology
Exchange: NASDAQ
Currency: USD

What changed lately

Latest deck · Mar 12, 2026
IPO Roadshow (March 2026)
IPO roadshow · 43 slides

Latest news

Bonus Biogroup Appoints Renowned Cell Therapy Leader, Professor Edwin M. Horwitz, MD, PhD, to its Advisory Board

Jul 14, 2025

Bonus Biogroup Announces U.S. Food and Drug Administration (FDA) Clearance of an Investigational New Drug (IND) Application for MesenCure™ Phase III Clinical Study in Respiratory Distress

Feb 20, 2025

All Bonus Biogroup Ltd. news

Decks

IPO Roadshow (March 2026)
IPO roadshow · 43 slides · Mar 12, 2026
Investor Presentation (2025)
Investor deck · 42 slides · 2025

Bonus Biogroup Ltd. on 6ix

Sector: Health care
Industry: Biotechnology
News releases: 2 in all · newest Jul 14, 2025 · oldest 2025
Decks: 2 decks · latest Mar 12, 2026

Where Bonus Biogroup Ltd. is listed

Listing	Exchange	Country	Currency
TASE:BONS · Home listing	TASE	Israel	ILA
NASDAQ:BONS · This page	NASDAQ	United States	USD
OTC:BBIXF	OTC	United States	USD

Log in to ask 6ix AI your own questions about Bonus Biogroup Ltd.